Executive in Residence
The Medical Industry Leadership Institute (MILI) Executive in Residence (EIR) Program is comprised of highly accomplished healthcare industry leaders who enhance the academic environment of MILI by sharing their professional expertise. EIRs engage directly with students and faculty by participating in activities such as teaching, mentoring, and coaching as well as interacting with the Carlson School, the University and business communities to advance the mission of MILI.
Establish Carlson as one of the most prestigious business schools that is especially well known for MILI, the strength in medical industry and resulting placement power for its graduates in the medical industry. EIRs will:
- Expand the medical industry competencies of MILI/Carlson students by:
- Providing insight regarding emerging dynamics and opportunities in medical industry.
- Leveraging their relationships to identify other experts in the medical industry who can share their industry expertise.
- Identifying priority areas for adding and/or revising MILI’s curriculum.
- Support students in pursuing professional opportunities by:
- Broadening students’ awareness regarding how and where to leverage their talent and advanced degree in the market.
- Offering individual career advice and mentoring.
- Coaching students on resume development, networking tactics, and interviewing skills.
- Making personalized introductions and recommendations, as appropriate, to potential employers.
- Engage with faculty to make academic research relevant to medical industry businesses by:
- Being accessible to faculty and offering insight to real-life business dynamics.
- Identifying opportunities to conduct “translational research” that puts faculty members’ research into practice.
Daniel Cosentino is CEO & President of ElectroSea, a firm that has developed a patent pending electrochemical management system to prevent unwanted marine growth in vessel seawater conduits. The company is developing an array of electrochemical technologies for industrial applications. Mr. Cosentino was CEO and founder of CARDIOCOM, a medical device and digital health solutions company, that he led for 16 years through the startup, growth, and acquisition by Medtronic for $200 million. CARDIOCOM received numerous awards for its innovative technology including North American Award for Enabling Technology, and North American Patient Monitoring Product Innovation of the Year. Mr. Cosentino is an expert in telehealth systems and holds 8 issued U.S. Patents. He currently serves on the Strategic Advisory Board for Minnetronix Neuro and has held executive positions at Guidant (now Boston Scientific) and Minntech (now Cantel Medical). Mr. Cosentino earned his Master in Business Administration from Boston University, and Bachelor of Arts in Physiology from University of Minnesota.
Michael Finch, Ph.D., received his degree in Sociology from the University of Minnesota. Dr. Finch is known for his work on the cost, quality and financing of health care in the public and private market and is nationally recognized has as an expert in research methods and evaluation. From 1984 through 1998 he was a member of the faculty of the Division of Health Services Research and Policy at the University of Minnesota. From 1998 through 2004 Dr. Finch was Director of Research Programs for UnitedHealth Group. He currently serves as an Executive in Residence in the Medical Industry Leadership Institute in the Carlson School of Management and serves as Manger, design and analytics at Children’s Hospital and Clinics.
Dr. Finch’s community service includes Chair of the Board of the Minnesota Housing Finance Agency from 1995 through 2011 and a member and Chair of the Board of the Healthier Minnesota Community Clinic Fund Board from 2004-2008.
Paul Gam is co-founder and CEO of Zurich Medical, which develops proprietary cardiac and vascular devices that are easier and more cost-effective to use, and are designed specifically to serve health care environments that are resource constrained. He serves on the Board of Trustees of Blue Cross and Blue Shield of Minnesota and is a partner of Grace Associates, a strategic advisory firm.
Mr. Gam was Vice President, International Development at St. Jude Medical (now part of Abbott Laboratories), where he led mergers and acquisitions, developed strategic alliances, and drove other business development initiatives for the $3 billion International Division from 2002 to 2011. He established the company's first Wholly Owned Foreign Enterprise in China and served as its Legal Representative and Chairman of the Board.
From 1997 to 2002, Mr. Gam served at Medtronic, where he was Director of Finance for the Cardiac Rhythm Disease Management business, and then head of Global Internal Audit.
Mr. Gam served as an advisor to the Robert Wood Johnson Foundation. He was the Chairman of the Minnesota World Trade Center and an advisor to Minnesota gubernatorial international trade missions. He served on the Minnesota Commission on Judicial Selection and the Board of Judicial Standards. Under his leadership as Chapter President, Minnesota was twice awarded Best Chapter of the Year by the OCA, a national organization dedicated to advancing the social, political, and economic well-being of Asian-Pacific Americans in the United States. Mr. Gam also served on the Professional Ethics Committee of the Minnesota Society of CPAs.
Mr. Gam is a W.K. Kellogg National Fellow, a Salzburg Global Fellow, a Bush Foundation Leadership Fellow, and an NACD Governance Fellow. He was the recipient of the Minneapolis/St. Paul Business Journal Minority Business Executive Award, the CityBusiness 40 Under 40 Award, and the Twin Cities International Citizen Award.
Mr. Gam is a graduate of Queen's College in Hong Kong. He earned a Bachelor of Science in Accounting and a Master of Business Administration at the Carlson School of Management.
Mr. Gam and his wife Queenie have three children and reside in Saint Paul, Minnesota.
Dr. Julia Halberg is a physician and business executive leveraging her medical background and passion for healthcare quality improvement to deliver innovative and disruptive health and well-being strategies. Most recently she led General Mills’ Global Health department as their Chief Medical Officer managing its on-site clinic, designing the company’s global approach to preventive care, providing health advocacy to employees, and partnering with the Benefits team to implement company-wide well-being programs.
Prior to working for General Mills, Julia worked in private practice, hospital-based health systems, and with insurers in the areas of workers’ compensation and disability management. Her diverse background gives her a deep understanding of the healthcare industry from multiple perspectives. Her areas of expertise include employer health solutions leading to value-driven health care with improved quality and cost-appropriate care.
Julia earned her medical degree from the University of Connecticut. She received a Master of Science degree in biology/ecology and a Master of Public Health degree in epidemiology from the University of Minnesota.
Vital, A Toshiba Medical Systems Group Company
Julie Kemp, Vice President, Marketing joined Vital in December, 2013. Ms. Kemp leads all aspects of global marketing within Vital, including product management, commercialization, medical education programs, and marketing communication. Ms. Kemp has over 15 years of cross-functional marketing experience at both Medtronic and GE Healthcare, with her most recent role leading Global Market Development for the Cardiac Rhythm and Diagnostics Division at Medtronic. During her earlier professional career, she managed global pre-market clinical trials and was a field clinical engineer. Ms. Kemp earned her Bachelor of Science in Biomedical Engineering from the University of Minnesota, and her Master in Business Administration from the Carlson School of Management at the University of Minnesota.
Mr. Nelson has been responsible for the development of medical devices for over 30 years at both emerging and larger medical device companies. Mr. Nelson has held management positions at St. Jude Medical Inc., Boston Scientific Corporation, Angeion Corporation; and Cardiac Pacemakers, Inc.
Mr. Nelson has 13 issued patents in the field of medical devices. He has a Mechanical Engineering degree from the University of Minnesota and an Economics degree from Willamette University in Salem, Oregon. From 2009-2015, Mr. Nelson was an Adjunct Faculty member of the Carlson School of Management, University of Minnesota, where he taught a graduate level course in the valuation of new medical innovations.
From 2006 until May of 2014 he served as the President and CEO for LifeScience Alley and The BioBusiness Alliance of Minnesota. From 2007 until 2009 Dale led efforts to develop a long-term strategy called Destination 2025 that focuses on the development and growth of high potential biology based industries in the state of MN. From 2011 until 2013 he served as the Founding Executive Director of the Medical Device Innovation Consortium (MDIC), a public private partnership between the FDA and the medical device industry with a mission to enhance the productivity of the medical device eco-system within the United States.
Today he is the President and CEO of Act 3, LLC, a consulting, engineering, and investment firm that focuses on helping companies to expand their global markets, assisting start up companies, and providing unique program management services in the development of capabilities that extend across public and private sectors. Act 3 has established an experienced global network of professionals that can be leveraged to meet the needs of virtually any high knowledge content company ranging from an early stage startup to fortune 500 global enterprises.